alpha1-ADRENOCEPTORANTAGONISTS TERAZOSIN AND DOXAZOSIN INDUCE PROSTATE APOPTOSIS WITHOUT AFFECTING CELL PROLIFERATION IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA-Reference-Cited by-同舟云学术

alpha1-ADRENOCEPTORANTAGONISTS TERAZOSIN AND DOXAZOSIN INDUCE PROSTATE APOPTOSIS WITHOUT AFFECTING CELL PROLIFERATION IN PATIENTS WITH BENIGN PROSTATIC HYPERPLASIA

Published:1999-06 Issue:6 Volume:161 Page:2002-2008
ISSN:0022-5347
Container-title:Journal of Urology
language:en
Short-container-title:Journal of Urology

Author:

CHON JOANNA K.,BORKOWSKI ANDREW,PARTIN ALAN W.,ISAACS JOHN T.,JACOBS STEPHEN C.,KYPRIANOU NATASHA

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Urology

Reference36 articles.

1. Induction of prostate apoptosis by doxazosin in benign prostatic hyperplasia;Kyprianou;J. Urol.,1998

2. The pathophysiology of lower urinary tract symptoms in the ageing male population;Lepor;Br. J. Urol.,1998

3. Benign prostatic hyperplasia: a review of its histogenesis and natural history;Oesterling;Prostate,1996

4. Origin and evolution of benign prostatic enlargement;McNeal;Invest. Urol.,1978

5. Alpha-adrenergic mechanisms in dynamics of benign prostatic hypertrophy;Caine;Urology,1988

Cited by 125 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Current and Emerging Pharmacological Targets and Treatments of Urinary Incontinence and Related Disorders;Pharmacological Reviews;2023-03-14

2. KRT4 suppresses oral squamous cell carcinoma development by reducing ATG4B-mediated autophagy;BIOCELL;2022

3. KRT4 suppresses oral squamous cell carcinoma development by reducing ATG4B-mediated autophagy;BIOCELL;2022

4. Concentration-dependent alpha1-Adrenoceptor Antagonism and Inhibition of Neurogenic Smooth Muscle Contraction by Mirabegron in the Human Prostate;Frontiers in Pharmacology;2021-06-24

5. Piperazine-Derived α1D/1A Antagonist 1- Benzyl-N- (3-(4- (2-Methoxyphenyl) Piperazine-1-yl) Propyl) -1H- Indole-2- Carboxamide Induces Apoptosis in Benign Prostatic Hyperplasia Independently of α1-Adrenoceptor Blocking;Frontiers in Pharmacology;2021-01-27